ArticleFrontiers in immunology2025
The POSH scaffold protein is essential for signal coordination leading to CD8 T cell differentiation and survival.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Upon antigen recognition, naive CD8 T cells must induce c-JUN N-terminal kinase (JNK), NF-κB, and Akt signaling to drive differentiation and generate a heterogeneous effector response. While the roles of these three pathways individually in mediating essential cellular responses for CD8 T cell differentiation are well established, the mechanisms of signal integration and crosstalk between these pathways to produce a diverse and heterogeneous response to infection remain poorly understood. Here, we establish the critical role of the Plenty of SH3 Domains (POSH) scaffold protein in coordinating signals from all three pathways to support CD8 T cell differentiation and fate. Methods: Using novel conditional T cell POSH knockout reporter mouse models (as POSHfl/fl CD4-Cre eGFP, POSHfl/fl GzmB-Cre eGFP), we determined the phenotype of T cells in the thymus and periphery through flow cytometry. Polyclonal and OT1 TCR transgenic POSH cKO CD8 T cells were stimulated in vitro and analyzed by flow cytometry to assess cell fate. JNK, NF-κB, and Akt pathways were examined via flow cytometry and immunoblotting. Purified OT1 CD8 T cells from these mice were adoptively transferred and subsequently challenged with VSV-OVA infection; their phenotype, effector function, and signaling were then assessed ex vivo by flow cytometry. Results: We demonstrate that POSH is essential for proper induction of the JNK, NF-κB, and Akt pathways. Furthermore, the absence of these signals due to POSH deficiency results in reduced differentiation into short-lived effector cells (SLECs), delayed proliferation, and decreased survival of memory precursor cells (MPECs) during the contraction phase. Conclusions: Collectively, these data identify POSH as a key regulator of CD8 T cell fate and enhance our understanding of the complex mechanisms governing signal integration during CD8 T cell responses to infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.